Synthesis of New Benzothiazole Acylhydrazones as Anticancer Agents

During the last five decades, a large number of BT (Benzothiazole) derivatives formed one of the eligible structures in medicinal chemistry as anticancer agents. Most of the studies reveal that various substitutions at specific positions on BT scaffold modulate the antitumor property. The potential...

Full description

Bibliographic Details
Main Authors: Derya Osmaniye, Serkan Levent, Abdullah Burak Karaduman, Sinem Ilgın, Yusuf Özkay, Zafer Asım Kaplancıklı
Format: Article
Language:English
Published: MDPI AG 2018-05-01
Series:Molecules
Subjects:
C6
Online Access:http://www.mdpi.com/1420-3049/23/5/1054
id doaj-b0ea3a44111d40999efa641702670410
record_format Article
spelling doaj-b0ea3a44111d40999efa6417026704102020-11-24T22:12:49ZengMDPI AGMolecules1420-30492018-05-01235105410.3390/molecules23051054molecules23051054Synthesis of New Benzothiazole Acylhydrazones as Anticancer AgentsDerya Osmaniye0Serkan Levent1Abdullah Burak Karaduman2Sinem Ilgın3Yusuf Özkay4Zafer Asım Kaplancıklı5Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, 26470 Eskişehir, TurkeyDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, 26470 Eskişehir, TurkeyDepartment of Pharmaceutical Toxicology, Faculty of Pharmacy, Anadolu Universty, 26470 Eskişehir, TurkeyDepartment of Pharmaceutical Toxicology, Faculty of Pharmacy, Anadolu Universty, 26470 Eskişehir, TurkeyDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, 26470 Eskişehir, TurkeyDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, 26470 Eskişehir, TurkeyDuring the last five decades, a large number of BT (Benzothiazole) derivatives formed one of the eligible structures in medicinal chemistry as anticancer agents. Most of the studies reveal that various substitutions at specific positions on BT scaffold modulate the antitumor property. The potential of BTs encouraged us to synthesize a number of new 2-((5-substitutedbenzothiazol-2-yl)thio)-N’-(2-(4-(substitutedphenyl)ethylidene)acetohydrazide derivatives and investigate their probable anticancer activity. 4-Substitued benzaldehyde derivatives (1a–1e) were afforded by the reaction of appropriate secondary amine and 4-fluorobenzaldehyde in DMF. Equimolar quantitates of 5-substitutedbenzothiazole-2-thiol, ethyl chloroacetate and K2CO3 were refluxed in acetone to obtain 2-((5-substitutedbenzothiazol-2-yl)thio)acetate derivatives (2a,2b), which reacted with excess of hydrazine hydrate to get 2-((5-substitutebenzothiazol-2-yl)thio)acetohydrazides (3a,3b). In the last step, 2-((5-substitutedbenzothiazol-2-yl)thio)-N’-(4-substitutedbenzylidene)acetohydrazide derivatives (4a–4j) were synthesized by the reaction of 1a–1e and 3a–3b in EtOH. The anticancer activity of target compounds was evaluated in three steps. First, an MTT test (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) was performed to observe cytotoxic activity of the compounds against carcinogenic C6 (Rat brain glioma cell line), A549 (Human lung adenocarcinoma epithelial cell line), MCF-7 (Human breast adenocarcinoma cell line), and HT-29 (Human colorectal adenocarcinoma cell line) cancer cell lines. Healthy NIH3T3 (Mouse embryo fibroblast cell line) cells were also subjected to MTT assay to determine selectivity of the compounds towards carcinogenic cell lines. Secondly, inhibitory effects of selected compounds 4d, 4e, and 4h on DNA synthesis of C6 cells were investigated. Finally, flow cytometric analysis were performed to identify the death pathway of the carcinogenic cells.http://www.mdpi.com/1420-3049/23/5/1054benzothiazolehydrazoneanticancerC6A549MCF-7HT-29apoptosis
collection DOAJ
language English
format Article
sources DOAJ
author Derya Osmaniye
Serkan Levent
Abdullah Burak Karaduman
Sinem Ilgın
Yusuf Özkay
Zafer Asım Kaplancıklı
spellingShingle Derya Osmaniye
Serkan Levent
Abdullah Burak Karaduman
Sinem Ilgın
Yusuf Özkay
Zafer Asım Kaplancıklı
Synthesis of New Benzothiazole Acylhydrazones as Anticancer Agents
Molecules
benzothiazole
hydrazone
anticancer
C6
A549
MCF-7
HT-29
apoptosis
author_facet Derya Osmaniye
Serkan Levent
Abdullah Burak Karaduman
Sinem Ilgın
Yusuf Özkay
Zafer Asım Kaplancıklı
author_sort Derya Osmaniye
title Synthesis of New Benzothiazole Acylhydrazones as Anticancer Agents
title_short Synthesis of New Benzothiazole Acylhydrazones as Anticancer Agents
title_full Synthesis of New Benzothiazole Acylhydrazones as Anticancer Agents
title_fullStr Synthesis of New Benzothiazole Acylhydrazones as Anticancer Agents
title_full_unstemmed Synthesis of New Benzothiazole Acylhydrazones as Anticancer Agents
title_sort synthesis of new benzothiazole acylhydrazones as anticancer agents
publisher MDPI AG
series Molecules
issn 1420-3049
publishDate 2018-05-01
description During the last five decades, a large number of BT (Benzothiazole) derivatives formed one of the eligible structures in medicinal chemistry as anticancer agents. Most of the studies reveal that various substitutions at specific positions on BT scaffold modulate the antitumor property. The potential of BTs encouraged us to synthesize a number of new 2-((5-substitutedbenzothiazol-2-yl)thio)-N’-(2-(4-(substitutedphenyl)ethylidene)acetohydrazide derivatives and investigate their probable anticancer activity. 4-Substitued benzaldehyde derivatives (1a–1e) were afforded by the reaction of appropriate secondary amine and 4-fluorobenzaldehyde in DMF. Equimolar quantitates of 5-substitutedbenzothiazole-2-thiol, ethyl chloroacetate and K2CO3 were refluxed in acetone to obtain 2-((5-substitutedbenzothiazol-2-yl)thio)acetate derivatives (2a,2b), which reacted with excess of hydrazine hydrate to get 2-((5-substitutebenzothiazol-2-yl)thio)acetohydrazides (3a,3b). In the last step, 2-((5-substitutedbenzothiazol-2-yl)thio)-N’-(4-substitutedbenzylidene)acetohydrazide derivatives (4a–4j) were synthesized by the reaction of 1a–1e and 3a–3b in EtOH. The anticancer activity of target compounds was evaluated in three steps. First, an MTT test (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) was performed to observe cytotoxic activity of the compounds against carcinogenic C6 (Rat brain glioma cell line), A549 (Human lung adenocarcinoma epithelial cell line), MCF-7 (Human breast adenocarcinoma cell line), and HT-29 (Human colorectal adenocarcinoma cell line) cancer cell lines. Healthy NIH3T3 (Mouse embryo fibroblast cell line) cells were also subjected to MTT assay to determine selectivity of the compounds towards carcinogenic cell lines. Secondly, inhibitory effects of selected compounds 4d, 4e, and 4h on DNA synthesis of C6 cells were investigated. Finally, flow cytometric analysis were performed to identify the death pathway of the carcinogenic cells.
topic benzothiazole
hydrazone
anticancer
C6
A549
MCF-7
HT-29
apoptosis
url http://www.mdpi.com/1420-3049/23/5/1054
work_keys_str_mv AT deryaosmaniye synthesisofnewbenzothiazoleacylhydrazonesasanticanceragents
AT serkanlevent synthesisofnewbenzothiazoleacylhydrazonesasanticanceragents
AT abdullahburakkaraduman synthesisofnewbenzothiazoleacylhydrazonesasanticanceragents
AT sinemilgın synthesisofnewbenzothiazoleacylhydrazonesasanticanceragents
AT yusufozkay synthesisofnewbenzothiazoleacylhydrazonesasanticanceragents
AT zaferasımkaplancıklı synthesisofnewbenzothiazoleacylhydrazonesasanticanceragents
_version_ 1725802367212847104